DHR vs PYPL: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and PayPal Holdings, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
PayPal Holdings, Inc. · Financial Services
$50.39
+110.0% upside to fair value
Grade B
QuantHub Verdict
PYPL has more upside to fair value
(+110.0%).
PYPL trades at a lower forward P/E
(9.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
PYPL |
| Current Price |
$174.04 |
$50.39 |
| Fair Value Estimate |
$197.01 |
$105.84 |
| Upside to Fair Value |
+13.2%
|
+110.0%
|
| Market Cap |
$123.2B |
$45.3B |
| Forward P/E |
33.4x
|
9.0x
|
| EV / EBITDA |
20.3x
|
6.1x
|
| Price / Sales |
5.0x
|
1.4x
|
| Price / FCF |
23.3x
|
8.2x
|
| Revenue Growth YoY |
+3.7%
|
+3.7%
|
| Gross Margin |
60.7%
|
46.6%
|
| Operating Margin |
21.0%
|
18.3%
|
| Return on Equity |
7.1%
|
25.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
12.27%
|
| Analyst Consensus |
Strong Buy
|
Sell
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
PayPal Holdings, Inc. operates as a leading digital payments platform offering transaction processing and value-added financial services such as consumer credit and BNPL products. The business quality is medium due to a narrowing competitive moat amid increasing pressure from big tech competitors and slowing growth in its core branded checkout segment. The stock is currently mispriced and cheap, …
Accumulation Zones
| Metric |
DHR |
PYPL |
| Zone Low |
$147.76 |
$79.38 |
| Zone High |
$167.46 |
$89.96 |
| In Buy Zone? |
No
|
Yes
|